Table 3.
(A). Total Cohort [n = 4982] |
(B). Regional Anesthesia (RA) [n = 4213] |
||||||||
---|---|---|---|---|---|---|---|---|---|
Variable | Reference | βz | 95% CI | p | βz | 95% CI | p | ||
(intercept) | −0.27 | −0.58 | 0.05 | 0.114 | −0.30 | −0.66 | 0.07 | 0.125 | |
Peri-operative care group: | |||||||||
Intra-operative [only] | [vs. Incomplete] | −0.27 | −0.42 | −0.11 | 0.001 | −0.24 | −0.40 | −0.07 | 0.005 |
Post-operative [only] | [vs. Incomplete] | −0.07 | −0.19 | 0.04 | 0.206 | −0.01 | −0.15 | 0.12 | 0.837 |
Full care | [vs. Incomplete] | −0.36 | −0.49 | −0.23 | <0.001 | −0.36 | −0.51 | −0.22 | <0.001 |
Anesthesia: | not modelled | ||||||||
General anesthesia | [vs. RA ] | 0.16 | 0.04 | 0.28 | 0.009 | ||||
Combined RA & GA | [vs. RA] | 0.04 | −0.14 | 0.22 | 0.663 | ||||
Age | [years] | 0.00 | −0.01 | 0.00 | 0.140 | 0.00 | −0.01 | 0.00 | 0.266 |
Pre-existing chronic pain | [vs. no] | 0.21 | 0.11 | 0.31 | <0.001 | 0.17 | 0.07 | 0.28 | 0.002 |
Intra-operative: neuraxial morphine | [vs. others/none] | not modelled | −0.16 | −0.27 | −0.05 | 0.004 | |||
Ward: opioid | [vs. no] | 0.17 | 0.10 | 0.25 | <0.001 | 0.20 | 0.12 | 0.28 | <0.001 |
Income level: high | [vs. others] | 0.32 | −0.06 | 0.70 | 0.119 | 0.31 | −0.11 | 0.73 | 0.162 |
R2 (total cohort, marginal, and conditional): 0.025 and 0.22. R2 (regional anesthesia, marginal, and conditional): 0.04 and 0.25.